Effect of High Altitude Exposure, Acclimatization and Re-exposure on Cerebral Autoregulation in Lowlanders
1 other identifier
interventional
21
1 country
1
Brief Summary
Prospective interventional trial in lowlanders evaluating the effect of acute exposure, acclimatization and re-exposure to high altitude on cerebral autoregulation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2016
CompletedStudy Start
First participant enrolled
April 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 4, 2016
CompletedFirst Posted
Study publicly available on registry
July 12, 2016
CompletedJanuary 17, 2019
January 1, 2019
25 days
April 1, 2016
January 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.
Change in magnitude of the coefficient of coherence between blood flow velocity in the middle cerebral artery measured by transcranial ultrasound Doppler and systemic blood pressure at day 2 (5050 m) vs. day 1 (520 m) of the first cycle
day 1; day 2 first cycle
Secondary Outcomes (4)
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.
day 1; day 7 first cycle
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.
day 2; day 7 second cycle
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.
day 2 first cycle; day 2 second cycle
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.
day 7 first cycle; day 7 second cycle
Study Arms (1)
Altitude exposure
EXPERIMENTALAcute high altitude exposure followed by 8 day acclimatization and reexposure for 8 days after 6 days at low altitude
Interventions
Eligibility Criteria
You may qualify if:
- Born, raised and currently living \<800m
- No overnight stay at altitudes \>1500 m 4 weeks before the study
You may not qualify if:
- Previous altitude intolerance to altitude \<3000 m
- Pregnancy
- Health impairment, which requires regular treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- University of Calgarycollaborator
Study Sites (1)
University of Zurich
Zurich, 8091, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Konrad E Bloch, MD
University of Zurich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2016
First Posted
July 12, 2016
Study Start
April 9, 2016
Primary Completion
May 4, 2016
Study Completion
May 4, 2016
Last Updated
January 17, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share